EX9924-4473: Semaglutide cardiovascular outcomes trial in patients with type 2 diabetes (SOUL)

  • STATUS
    Recruiting
Updated on 23 November 2020

Summary

Oral Semaglutide

 

Description

  • Anticipated to continue until 2025
  • 1:1 randomization of semaglutide or placebo
  • Details
    Condition Diabetes Mellitus, Type 2, Heart Attack (Myocardial Infarction), Stroke, Diabetes Mellitus Type 2
    Clinical Study IdentifierTX240843
    Last Modified on23 November 2020

    Eligibility

    Yes No Not Sure

    Inclusion Criteria

    Type II Diabetes, history of heart attack, stroke, CABG, coronary stent, and other cardiovascular qualifications
    HbA1C 6.5-10%
    No current use of GLP-1 medications
    Clear my responses

    How to participate?

    Step 1 Connect with a site
    What happens next?
    • You can expect the study team to contact you via email or phone in the next few days.
    • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

    You are contacting

    Investigator Avatar
    Name

    Primary Contact

    site
    Name

    0/250
    Preferred Language
    Other Language
    Please verify that you are not a bot.

    Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

    Learn more

    If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

    Learn more

    Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

    Learn more

    Similar trials to consider

    Loading...

    Not finding what you're looking for?

    Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

    Sign up as volunteer

    user name

    Added by • 

     • 

    Private

    Reply by • Private
    Loading...

    Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

      The passcode will expire in None.
    Loading...

    No annotations made yet

    Add a private note
    • abc Select a piece of text from the left.
    • Add notes visible only to you.
    • Send it to people through a passcode protected link.
    Add a private note